| Segment | Revenue | Share |
|---|---|---|
Products, Other HIV | $20.75B | 79.7% |
Cell Therapy Products, Total Cell Therapy Product Sales | $2.18B | 8.4% |
Trodelvy | $1.40B | 5.4% |
Veklury | $911.0M | 3.5% |
Other Products, Total Other product sales | $799.0M | 3.1% |
Other | $0 | 0.0% |
| Segment | Revenue | Share |
|---|---|---|
UNITED STATES | $20.88B | 70.9% |
Europe | $5.06B | 17.2% |
Other International | $3.50B | 11.9% |
Other | $0 | 0.0% |